{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T09:30:24Z","timestamp":1775986224880,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.antiviral.2010.03.007","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T08:21:03Z","timestamp":1269246063000},"page":"276-285","source":"Crossref","is-referenced-by-count":25,"title":["Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice"],"prefix":"10.1016","volume":"86","author":[{"given":"Jenny","family":"Rowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer F.","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.03.007_bib1","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1002\/j.1460-2075.1996.tb00998.x","article-title":"A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network","volume":"15","author":"Alconada","year":"1996","journal-title":"Embo J."},{"key":"10.1016\/j.antiviral.2010.03.007_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1034\/j.1600-0773.2002.910505.x","article-title":"In vitro cytotoxicity of protocatechuic acid to cultured human cells from oral tissue: involvement in oxidative stress","volume":"91","author":"Babich","year":"2002","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/viro.1997.8489","article-title":"Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication","volume":"231","author":"Bresnahan","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2010.03.007_bib4","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1128\/JVI.00081-09","article-title":"Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus","volume":"83","author":"Carpenter","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/viro.2000.0741","article-title":"Varicella-zoster virus (VZV) ORF65 virion protein is dispensable for replication in cell culture and is phosphorylated by casein kinase II, but not by the VZV protein kinases","volume":"280","author":"Cohen","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2010.03.007_bib6","first-page":"2707","article-title":"Varicella-zoster virus and its replication","volume":"vol.2","author":"Cohen","year":"2001"},{"key":"10.1016\/j.antiviral.2010.03.007_bib7","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1016\/j.bmc.2009.06.024","article-title":"Identification of potential cellular targets of aloisine A by affinity chromatography","volume":"17","author":"Corbel","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2010.03.007_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib9","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1128\/JVI.78.17.9352-9365.2004","article-title":"Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors","volume":"78","author":"Diwan","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.copbio.2009.01.007","article-title":"Advances in bioluminescence imaging of live animal models","volume":"20","author":"Dothager","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib11","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nm1606","article-title":"Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC","volume":"13","author":"Goga","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2010.03.007_bib12","doi-asserted-by":"crossref","first-page":"29135","DOI":"10.1074\/jbc.M503312200","article-title":"Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity","volume":"280","author":"Habran","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"Suppl A","key":"10.1016\/j.antiviral.2010.03.007_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/3.suppl_A.63","article-title":"The effect of phosphonoacetic acid on herpes viruses","volume":"3","author":"Hay","year":"1977","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2010.03.007_bib14","first-page":"863","article-title":"A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia","volume":"5","author":"Holcomb","year":"2006","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib15","first-page":"93","article-title":"Preferential inhibition of herpes-group viruses by phosphonoacetic acid: effect on virus DNA synthesis and virus-induced DNA polymerase activity","volume":"49","author":"Huang","year":"1976","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.antiviral.2010.03.007_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/0002512-200825120-00002","article-title":"Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient","volume":"25","author":"Johnson","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.antiviral.2010.03.007_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/bj20020665","article-title":"Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis","volume":"367","author":"Kabir","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2010.03.007_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1074-5521(00)00124-1","article-title":"Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors","volume":"7","author":"Knockaert","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib19","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/sj.onc.1205908","article-title":"p42\/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol","volume":"21","author":"Knockaert","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2010.03.007_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/JVI.78.1.104-115.2004","article-title":"Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication","volume":"78","author":"Kudoh","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib21","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1128\/JVI.00163-06","article-title":"Varicella-zoster virus infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity","volume":"80","author":"Leisenfelder","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib22","doi-asserted-by":"crossref","first-page":"12116","DOI":"10.1128\/JVI.00153-08","article-title":"Cyclin-dependent kinase 1\/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions","volume":"82","author":"Leisenfelder","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib23","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.76.23.12149-12161.2002","article-title":"Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice","volume":"76","author":"Luker","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2008.01.158","article-title":"Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation","volume":"78","author":"Luker","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.03.007_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1432-1033.1990.tb15280.x","article-title":"Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1","volume":"187","author":"Meggio","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.antiviral.2010.03.007_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1096\/fj.02-0473rev","article-title":"One-thousand-and-one substrates of protein kinase CK2?","volume":"17","author":"Meggio","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.antiviral.2010.03.007_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/ar0201198","article-title":"Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials","volume":"36","author":"Meijer","year":"2003","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.antiviral.2010.03.007_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm020319p","article-title":"Aloisines, a new family of CDK\/GSK-3 inhibitors, SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects","volume":"46","author":"Mettey","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2010.03.007_bib29","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/JVI.69.9.5236-5242.1995","article-title":"Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice","volume":"69","author":"Moffat","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/JVI.72.2.965-974.1998","article-title":"Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse","volume":"72","author":"Moffat","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib31","series-title":"Handbook of Animal Models of Infection","first-page":"973","article-title":"Varicella-zoster virus infection of T cells and skin in the SCID-hu mouse model","author":"Moffat","year":"1999"},{"key":"10.1016\/j.antiviral.2010.03.007_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbapap.2003.11.026","article-title":"Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis","volume":"1697","author":"Moffat","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2010.03.007_bib33","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.1128\/JVI.01526-09","article-title":"Phosphorylation of the nuclear form of varicella-zoster virus immediate-early protein 63 by casein kinase II at serine 186","volume":"83","author":"Mueller","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib34","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.vaccine.2004.03.062","article-title":"Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli","volume":"22","author":"Nagaike","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2010.03.007_bib35","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1128\/JVI.77.10.6062-6065.2003","article-title":"Construction of Varicella-zoster virus recombinants from parent oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model","volume":"77","author":"Niizuma","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jviromet.2008.07.033","article-title":"Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts","volume":"154","author":"Oliver","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2010.03.007_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/JVI.36.2.457-464.1980","article-title":"Mechanism of inhibition of herpes simplex virus and vaccinia virus DNA polymerases by aphidicolin, a highly specific inhibitor of DNA replication in eucaryotes","volume":"36","author":"Pedrali-Noy","year":"1980","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1074\/jbc.M410467200","article-title":"Mimosine attenuates serine hydroxymethyltransferase transcription by chelating zinc. Implications for inhibition of DNA replication","volume":"280","author":"Perry","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2010.03.007_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4615-5371-7_7","article-title":"Protein kinase CK2 (\u201ccasein kinase-2\u201d) and its implication in cell division and proliferation","volume":"3","author":"Pinna","year":"1997","journal-title":"Prog. Cell Cycle Res."},{"key":"10.1016\/j.antiviral.2010.03.007_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/15204559950020067","article-title":"Cell cycle analysis of cultured porcine mammary cells","volume":"1","author":"Prather","year":"1999","journal-title":"Cloning"},{"key":"10.1016\/j.antiviral.2010.03.007_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/1535-7163.353.3.3","article-title":"Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis","volume":"3","author":"Raynaud","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.antiviral.2010.03.007_bib42","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1016\/S0021-9258(18)83248-3","article-title":"Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate","volume":"264","author":"Reardon","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2010.03.007_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/A:1009608628076","article-title":"Mimosine induces apoptosis in the HL60 human tumor cell line","volume":"4","author":"Ren\u00f2","year":"1999","journal-title":"Apoptosis"},{"key":"10.1016\/j.antiviral.2010.03.007_bib44","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2010.03.007_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/84.3.274","article-title":"Herpes zoster (shingles) and postherpetic neuralgia","volume":"84","author":"Sampathkumar","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.antiviral.2010.03.007_bib46","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1128\/JVI.78.20.11219-11232.2004","article-title":"Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production","volume":"78","author":"Sanchez","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib47","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JVI.74.5.2107-2120.2000","article-title":"Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins","volume":"74","author":"Schang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1081\/NCN-200060314","article-title":"Cdk inhibitory nucleoside analogs prevent transcription from viral genomes","volume":"24","author":"Schang","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.antiviral.2010.03.007_bib49","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1586\/14787210.4.6.953","article-title":"First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapy","volume":"4","author":"Schang","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2010.03.007_bib50","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/JVI.78.6.2853-2862.2004","article-title":"Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus","volume":"78","author":"Taylor","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib51","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1128\/JVI.79.17.11501-11506.2005","article-title":"Replication of varicella-zoster virus in human skin organ culture","volume":"79","author":"Taylor","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib52","doi-asserted-by":"crossref","first-page":"13200","DOI":"10.1128\/JVI.01148-07","article-title":"A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9","volume":"81","author":"Tischer","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib53","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00000441-200106000-00003","article-title":"Zoster in patients infected with HIV: a review","volume":"321","author":"Vafai","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.antiviral.2010.03.007_bib54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"V\u00e1zquez","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2010.03.007_bib55","first-page":"1041","article-title":"Aphidicolin inhibits in vitro the activity of pseudorabies virus (PRV) DNA polymerase and in vivo the viral proliferation","volume":"8","author":"Verri","year":"1994","journal-title":"In Vivo"},{"key":"10.1016\/j.antiviral.2010.03.007_bib56","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ijc.10125","article-title":"Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities","volume":"97","author":"Villerbu","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2010.03.007_bib57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.tips.2008.03.003","article-title":"Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology","volume":"29","author":"Wang","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2010.03.007_bib58","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2003-05-1432","article-title":"Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging","volume":"102","author":"Wang","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2010.03.007_bib59","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/JVI.67.8.4464-4473.1993","article-title":"Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI","volume":"67","author":"Yao","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib60","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/JVI.73.2.1320-1330.1999","article-title":"Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase","volume":"73","author":"Ye","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib61","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1016\/j.vaccine.2007.04.064","article-title":"Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus","volume":"25","author":"Yoshii","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2010.03.007_bib62","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/JVI.01470-06","article-title":"Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway","volume":"81","author":"Zapata","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib63","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncpgasthep1274","article-title":"Interferon-based therapy for chronic hepatitis C: current and future perspectives","volume":"5","author":"Zeuzem","year":"2008","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2010.03.007_bib64","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1128\/JVI.02666-06","article-title":"Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system","volume":"81","author":"Zhang","year":"2007","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210005449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210005449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T04:03:00Z","timestamp":1685505780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210005449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0166354210005449"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.03.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}